Royal Holloway, University of London
Surrey, United Kingdom
Purpose
to design and evaluate so-called “infinite-epitope” vaccines for their potential to provide simultaneous and broad protective immunity to the many variant forms of HIV.
Division
Global Health
Date
May 2009
Region Served
GLOBAL
Committed amount
$100,000
Grant topic
Discovery and Translational Sciences
Duration (months)
18
Grantee location
Surrey, United Kingdom
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.